Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-09-02

Camp4 Therapeutics Corp (CAMP)

CEO Josh Mandel-Brehm was paid $3,327,238 in fiscal year 2025, ↑ up 45.0% from fiscal year 2024 (SEC filing 0001736730-26-000026 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$3,327,238 ↑
Josh Mandel-Brehm total, FY2025
—
CEO pay percentile vs peers
—
CEO-to-median pay ratio
—
Say-on-pay support, latest vote

Track this company's pay every filing: join the Pro seat waitlist

Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year

A confirmation now and one email when Pro opens, and nothing else. Privacy

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Josh Mandel-Brehm (President and Chief Executive Officer), FY2025 total compensation $3,327,238 (base salary $600,000) [exec_comp, SEC accession 0001736730-26-000026, filed 2026-04-23]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

CAMP's next annual pay disclosure, estimated April 16, 2027.est. Filing ↗

Page 2 of 34 of the Camp4 Therapeutics Corp Executive Compensation Report, as it is delivered: Executive Summary.

That is page 2 of 34 of the full Executive Compensation Report, shown as it is delivered. The rest:

  1. Summary Compensation Table
  2. Equity transactions since the proxy statement
  3. Grants of plan-based awards
  4. Outstanding equity awards at fiscal year-end
  5. Incentive-plan design (CD&A)
  6. Say-on-pay
  7. CEO pay ratio
  8. Director compensation
  9. Board fee structure and ownership guideline
  10. Disclosed peer group
  11. Source register

Every figure above cites the filing it came from (accession 0001736730-26-000026, filed 2026-09-02) — see the source register, §11.

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Josh Mandel-Brehm$600,000$0$0$2,430,988$285,750$0$10,500$3,327,238
President and Chief Executive Officer
Kelly Gold465,000001,112,042178,095091,5961,846,733
Chief Financial Officer
Yuri Maricich500,000001,112,042191,500010,5001,814,042
Chief Medical Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY2024→2025
Josh Mandel-Brehm$3,327,238$2,294,985—↑ +1,032,253
Kelly Gold1,846,7331,310,523—↑ +536,210
Yuri Maricich1,814,0422,521,505—↓ −707,463

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

You have just read Camp4 Therapeutics Corp's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper CAMP reports.

We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.

Get the Camp4 Therapeutics Corp Peer Teardown Report

$3,327,238 Josh Mandel-Brehm total, FY2025

$199

The free page is the headline. The teardown reads every company in the disclosed peer group on its own numbers.

Data as of September 2, 2026 · Source: 0001736730-26-000026 · Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

Reports for CAMP

Every report below is generated from the same filings as the free brief above, at the moment of purchase. What each one adds:

Executive Compensation ReportThe free page is the headline figures. The report is every award, peer and vote combined into one document you can hand to a committee.$1,500 →Reverse Peer AnalysisThe free page is the one line. The analysis reads every company that names this one in its own peer group.$299 →Peer Teardown ReportThe free page is the headline. The teardown reads every company in the disclosed peer group on its own numbers.$199 →
CAMPon Velarion Intel, free → The platform reading of this company, beside the same data as a subscription.

Order CAMP

Pick the report, add the email the receipt and the PDF go to, and pay by card on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

How we handle your data → Privacy

Companies that benchmark against CAMP
No companies currently name CAMP as a compensation peer in their most recent disclosure.

This is the complete answer, not a partial one — the list is never padded.

Get the Camp4 Therapeutics Corp Executive Compensation Report

$1,500

Buy the report - $1,500Both reports - $2,400
01b

Executives — the named officers

One page per officer: the same table above, read for one person at a time — his own figure and every fiscal year the register holds.

ExecutiveRoleFY2025 total
Josh Mandel-BrehmCEO$3,327,238
Kelly GoldCFO$1,846,733
Yuri MaricichChief Medical Officer$1,814,042
01c

Board of directors

One page per director: the seat, the committees and the fee table, read for one person at a time.

DirectorRoleFY2025 total
Amir Nashat, ScDIndependent Director$11,915
Andrew J. SchwabIndependent Director$12,692
Douglas Williams, PhDChair of the Board$120,723
James BoylanFormer director (through FY2025)$18,970
Michael HigginsIndependent Director$70,359
Michael MacLeanDirector—
Murray Stewart, DM FRCPIndependent Director$108,593
Paula Ragan, PhDFormer director (through FY2025)$47,859
Ravi Thadhani, MD, MPHFormer director (through FY2025)$44,109
Richard Young, PhDIndependent Director$156,915
Steven HoltzmanIndependent Director$164,109
02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Murray StewartDirector2026-06-10A28,000$0$0Derivative, Class A CommonForm 4 ↗
Richard Young, PhDDirector2026-06-10A28,00000Derivative, Class A CommonForm 4 ↗
Douglas Williams, PhDDirector2026-06-10A28,00000Derivative, Class A CommonForm 4 ↗
Amir NashatDirector2026-06-10A28,00000Derivative, Class A CommonForm 4 ↗
Andrew J. SchwabDirector2026-06-10A28,00000Derivative, Class A CommonForm 4 ↗
Steven HoltzmanDirector2026-06-10A28,00000Derivative, Class A CommonForm 4 ↗
Josh Mandel-BrehmDirector2026-08-03A6,551210,809CommonForm 4 ↗
Kelly GoldChief Financial Officer2026-08-03A6,551210,809CommonForm 4 ↗
Richard Young, PhDDirector2026-08-03A16,378227,024CommonForm 4 ↗
5AM Partners VI, LLCGreater-than-10% holder2026-08-03A3,179,55824,864,406Derivative, Class A CommonForm 4 ↗
Yuri MaricichChief Medical Officer2026-08-03A6,551210,809CommonForm 4 ↗
Andrew J. SchwabDirector2026-08-03A3,179,55824,864,406Derivative, Class A CommonForm 4 ↗
Andrew J. SchwabDirector2026-08-19D45,1475214,900Common, indirectForm 4 ↗
Daniel TardiffChief Scientific Officer2026-08-19D1,73858,273CommonForm 4 ↗
Andrew J. SchwabDirector2026-08-20D114,7005520,738Common, indirectForm 4 ↗
Andrew J. SchwabDirector2026-08-21D32,0185144,081Common, indirectForm 4 ↗
Andrew J. SchwabDirector2026-08-24D10545Common, indirectForm 4 ↗
Andrew J. SchwabDirector2026-08-27D400,00041,616,000Common, indirectForm 4 ↗
Kelly GoldChief Financial Officer2026-08-31A10,000439,600Common, indirectForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

03

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Kelly GoldOPTION2025-12-11——190,000——
Yuri MaricichOPTION2024-08-27——132,886——
Josh Mandel-BrehmOPTION2024-03-27——44,579——
Kelly GoldOPTION2025-04-01——80,000——
Kelly GoldOPTION2024-03-27——44,579——
Josh Mandel-BrehmOPTION2025-12-11——425,000——
Josh Mandel-BrehmOPTION2025-04-01——160,000——
Yuri MaricichOPTION2025-04-01——80,000——
Yuri MaricichOPTION2025-12-11——190,000——
03b

Vehicle mix — grant-date fair value by award type

Grant-level vehicle detail not disclosed.

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Josh Mandel-BrehmOption425,0006.01—
Yuri MaricichOption88,58112.79—
Kelly GoldRSU6,060—10,000
Josh Mandel-BrehmRSU6,060—10,000
Yuri MaricichRSU6,060—10,000
Kelly GoldOption88,58112.79—
Josh Mandel-BrehmOption130,0013.86—
Kelly GoldOption65,0013.86—
Kelly GoldOption17,3348.41—
Kelly GoldOption25,0719.08—
Kelly GoldOption190,0006.01—
Josh Mandel-BrehmOption4,1795.5—
Yuri MaricichOption65,0013.86—
Yuri MaricichOption190,0006.01—
Josh Mandel-BrehmOption64,0618.41—
Kelly GoldOption9185.5—
Josh Mandel-BrehmOption25,0719.08—
05

Incentive-plan design — the Compensation Discussion & Analysis

Our executive compensation program is designed to attract, retain and reward key employees, to incentivize them based on the achievement of key performance goals, and to align their interests with the interests of our stockholders.

CEO STI target (% of salary)50%
CEO LTI target (% of salary)—
Independent consultantAlpine
Clawback policytrue
Anti-hedgingtrue
Anti-pledgingtrue
07

CEO pay ratio

Ratio (CEO : median employee)—
CEO total compensation—
Median employee compensation—
08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Steven HoltzmanIndependent · Compensation (Chair) · Nominating/Governance (Chair)$78,750$0$10,359$0$75,000$164,109
Richard Young, PhDIndependent · Compensation46,556010,3590100,000156,915
Douglas Williams, PhDIndependent · Board Chair · Audit48,302072,4210—120,723
Murray Stewart, DM FRCPIndependent36,172072,4210—108,593
Michael HigginsIndependent · Audit (Chair) · Compensation · Not standing for re-election60,000010,3590—70,359
Paula Ragan, PhDIndependent · Departed during FY37,500010,3590—47,859
Ravi Thadhani, MD, MPHIndependent · Departed during FY33,750010,3590—44,109
James BoylanIndependent · Departed during FY8,611010,3590—18,970
Andrew J. SchwabIndependent · Audit2,333010,3590—12,692
Amir Nashat, ScDIndependent1,556010,3590—11,915
Josh Mandel-BrehmEmployee director000—00
Michael MacLeanAudit · Compensation · Newly elected000000
09

Board fee structure and ownership guideline

Annual cash retainer$40,000
Annual equity retainer$10,359
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)15,000 / 10,000 / 10,000
Stock ownership guideline—
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$353,530
Equity awards (grant-date value)$0
All other compensation$175,000
Total cost of the board$528,530

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Camp4 Therapeutics Corp2025Josh Mandel-Brehm$600,000$0$2,430,988$285,750$3,327,238

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10d

Frequently asked questions

Who was the highest-paid executive at Camp4 Therapeutics Corp in fiscal 2025?
As disclosed, Josh Mandel-Brehm (President and Chief Executive Officer) was the highest-paid executive at Camp4 Therapeutics Corp in fiscal 2025, with total compensation of $3,327,238.
How much does Camp4 Therapeutics Corp spend in total on board compensation for fiscal 2025?
As disclosed, Camp4 Therapeutics Corp reported total board compensation of $528,530 for fiscal 2025.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Josh Mandel-BrehmDEF 14A2026-04-230001736730-26-000026Section “Summary Compensation Table”. As printed: 3,327,238. Filing ↗machine: r2 · c36 · span 177042–177051
2Section 01, Kelly GoldDEF 14A2026-04-230001736730-26-000026Section “Summary Compensation Table”. As printed: 1,846,733. Filing ↗machine: r4 · c36 · span 182463–182472
3Section 01, Yuri MaricichDEF 14A2026-04-230001736730-26-000026Section “Summary Compensation Table”. As printed: 1,814,042. Filing ↗machine: r6 · c36 · span 187834–187843
4Section 03, Kelly Gold OPTIONDEF 14A2026-04-230001736730-26-000026Section “EXECUTIVE AND DIRECTOR COMPENSATION” · grants of plan-based awards table. Filing ↗machine: span 211199–211206
5Section 03, Yuri Maricich OPTIONDEF 14A2026-04-230001736730-26-000026Section “EXECUTIVE AND DIRECTOR COMPENSATION” · grants of plan-based awards table. Filing ↗machine: span 211745–211752
6Section 03, Josh Mandel-Brehm OPTIONDEF 14A2026-04-230001736730-26-000026Section “EXECUTIVE AND DIRECTOR COMPENSATION” · grants of plan-based awards table. Filing ↗machine: span 208710–208716
7Section 03, Kelly Gold OPTIONDEF 14A2026-04-230001736730-26-000026Section “EXECUTIVE AND DIRECTOR COMPENSATION” · grants of plan-based awards table. Filing ↗machine: span 210903–210909
8Section 03, Kelly Gold OPTIONDEF 14A2026-04-230001736730-26-000026Section “EXECUTIVE AND DIRECTOR COMPENSATION” · grants of plan-based awards table. Filing ↗machine: span 208710–208716
9Section 03, Josh Mandel-Brehm OPTIONDEF 14A2026-04-230001736730-26-000026Section “EXECUTIVE AND DIRECTOR COMPENSATION” · grants of plan-based awards table. Filing ↗machine: span 198196–198203
10Section 03, Josh Mandel-Brehm OPTIONDEF 14A2026-04-230001736730-26-000026Section “EXECUTIVE AND DIRECTOR COMPENSATION” · grants of plan-based awards table. Filing ↗machine: span 209115–209122
11Section 03, Yuri Maricich OPTIONDEF 14A2026-04-230001736730-26-000026Section “EXECUTIVE AND DIRECTOR COMPENSATION” · grants of plan-based awards table. Filing ↗machine: span 210903–210909
12Section 03, Yuri Maricich OPTIONDEF 14A2026-04-230001736730-26-000026Section “EXECUTIVE AND DIRECTOR COMPENSATION” · grants of plan-based awards table. Filing ↗machine: span 211199–211206
13Section 07, pay ratio10-K2026-03-050001736730-26-000016Section “CEO Pay Ratio”. As printed: —. Filing ↗
14Section 08, Steven HoltzmanDEF 14A2026-04-230001736730-26-000026Section “Director Compensation”. As printed: 164,109. Filing ↗machine: t7 · r2 · c12 · span 264808–265076
15Section 08, Richard Young, PhDDEF 14A2026-04-230001736730-26-000026Section “Director Compensation”. As printed: 156,915. Filing ↗machine: t7 · r3 · c12 · span 267168–267410
16Section 08, Douglas Williams, PhDDEF 14A2026-04-230001736730-26-000026Section “Director Compensation”. As printed: 120,723. Filing ↗machine: t7 · r4 · c12 · span 269186–269556
17Section 08, Murray Stewart, DM FRCPDEF 14A2026-04-230001736730-26-000026Section “Director Compensation”. As printed: 108,593. Filing ↗machine: t7 · r5 · c12 · span 271334–271704
18Section 08, Michael HigginsDEF 14A2026-04-230001736730-26-000026Section “Director Compensation”. As printed: 70,359. Filing ↗machine: t7 · r6 · c12 · span 273474–273843
19Section 08, Paula Ragan, PhDDEF 14A2026-04-230001736730-26-000026Section “Director Compensation”. As printed: 47,859. Filing ↗machine: t7 · r7 · c12 · span 275614–275983
20Section 08, Ravi Thadhani, MD, MPHDEF 14A2026-04-230001736730-26-000026Section “Director Compensation”. As printed: 44,109. Filing ↗machine: t7 · r8 · c12 · span 277760–278129
21Section 08, James BoylanDEF 14A2026-04-230001736730-26-000026Section “Director Compensation”. As printed: 18,970. Filing ↗machine: t7 · r9 · c12 · span 279895–280264
22Section 08, Andrew J. SchwabDEF 14A2026-04-230001736730-26-000026Section “Director Compensation”. As printed: 12,692. Filing ↗machine: t7 · r10 · c12 · span 282034–282403
23Section 08, Amir Nashat, ScDDEF 14A2026-04-230001736730-26-000026Section “Director Compensation”. As printed: 11,915. Filing ↗machine: t7 · r11 · c12 · span 284173–284542
24Section 08, Josh Mandel-BrehmDEF 14A2026-04-230001736730-26-000026Section “Director Compensation”. As printed: 0. Filing ↗
25Section 08, Michael MacLeanDEF 14A2026-04-230001736730-26-000026Section “Director Compensation”. As printed: 0. Filing ↗
26Section 02, Murray Stewart 2026-06-10Form 42026-06-120001628280-26-042859Insider equity transaction reported since the proxy statement. Filing ↗
27Section 02, Richard Young, PhD 2026-06-10Form 42026-06-120001628280-26-042862Insider equity transaction reported since the proxy statement. Filing ↗
28Section 02, Douglas Williams, PhD 2026-06-10Form 42026-06-120001628280-26-042863Insider equity transaction reported since the proxy statement. Filing ↗
29Section 02, Amir Nashat 2026-06-10Form 42026-06-120001628280-26-042858Insider equity transaction reported since the proxy statement. Filing ↗
30Section 02, Andrew J. Schwab 2026-06-10Form 42026-06-120001628280-26-042861Insider equity transaction reported since the proxy statement. Filing ↗
31Section 02, Steven Holtzman 2026-06-10Form 42026-06-120001628280-26-042860Insider equity transaction reported since the proxy statement. Filing ↗
32Section 02, Josh Mandel-Brehm 2026-08-03Form 42026-08-050001628280-26-053505Insider equity transaction reported since the proxy statement. Filing ↗
33Section 02, Kelly Gold 2026-08-03Form 42026-08-050001628280-26-053511Insider equity transaction reported since the proxy statement. Filing ↗
34Section 02, Richard Young, PhD 2026-08-03Form 42026-08-050001628280-26-053513Insider equity transaction reported since the proxy statement. Filing ↗
35Section 02, 5AM Partners VI, LLC 2026-08-03Form 42026-08-050001231919-26-000829Insider equity transaction reported since the proxy statement. Filing ↗
36Section 02, Yuri Maricich 2026-08-03Form 42026-08-050001628280-26-053512Insider equity transaction reported since the proxy statement. Filing ↗
37Section 02, Andrew J. Schwab 2026-08-03Form 42026-08-050001598549-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
38Section 02, Andrew J. Schwab 2026-08-19Form 42026-08-210001598549-26-000007Insider equity transaction reported since the proxy statement. Filing ↗
39Section 02, Daniel Tardiff 2026-08-19Form 42026-08-190001628280-26-058107Insider equity transaction reported since the proxy statement. Filing ↗
40Section 02, Andrew J. Schwab 2026-08-20Form 42026-08-210001598549-26-000007Insider equity transaction reported since the proxy statement. Filing ↗
41Section 02, Andrew J. Schwab 2026-08-21Form 42026-08-210001598549-26-000007Insider equity transaction reported since the proxy statement. Filing ↗
42Section 02, Andrew J. Schwab 2026-08-24Form 42026-08-260001598549-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
43Section 02, Andrew J. Schwab 2026-08-27Form 42026-08-310001598549-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
44Section 02, Kelly Gold 2026-08-31Form 42026-09-020001628280-26-060234Insider equity transaction reported since the proxy statement. Filing ↗
45Section 01 trend, Δ column (computed)Computed——Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
46Section 09b board cost (computed)Computed——Cash 353,530 + equity 0 + all other 175,000 = 528,530, summed across the director compensation table rows.machine: formula: Σ = 528,530
47Camp4 Therapeutics Corp (subject), Section 10b CEO totalDEF 14A2026-04-230001736730-26-000026CEO total compensation as printed in Camp4 Therapeutics Corp's own proxy. As printed: 3,327,238. Filing ↗machine: r2 · c36 · span 177042–177051

The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.

You'll confirm on The Pay Desk's sign-up page.

Get the Camp4 Therapeutics Corp Executive Compensation Report

$1,500

Buy the report - $1,500Both reports - $2,400
CAMP Peer Teardown Report